Burden and characteristics of skin pain among children with atopic dermatitis
Clinical Implications Skin pain is a distinct, burdensome symptom of childhood atopic dermatitis, with heterogeneous presentation and multiple atopic dermatitis phenotypes. [...]skin pain intensity is associated with significant decrements in quality of life, independent of atopic dermatitis severit...
Gespeichert in:
Veröffentlicht in: | The journal of allergy and clinical immunology in practice (Cambridge, MA) MA), 2022-04, Vol.10 (4), p.1104-1106.e1 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1106.e1 |
---|---|
container_issue | 4 |
container_start_page | 1104 |
container_title | The journal of allergy and clinical immunology in practice (Cambridge, MA) |
container_volume | 10 |
creator | Cheng, Brian T. Paller, Amy S. Griffith, James W. Silverberg, Jonathan I. Fishbein, Anna B. |
description | Clinical Implications Skin pain is a distinct, burdensome symptom of childhood atopic dermatitis, with heterogeneous presentation and multiple atopic dermatitis phenotypes. [...]skin pain intensity is associated with significant decrements in quality of life, independent of atopic dermatitis severity. Median skin pain intensity was 5.5 and was more intense in children with more severe disease. [...]skin pain intensity was associated with worse overall QOL in disease severity–adjusted models, similar to previous studies that found that AD-induced pruritus is associated with worse QOL.3 Yet, it is unclear whether the differences in QOL are clinically significant. Skin pain is a distinct, burdensome symptom of childhood AD with heterogeneous presentation and AD phenotypes. [...]skin pain intensity was associated with significant decrements on QOL, independent of disease severity. Given the link between skin pain and the severity of AD, skin pain may be an important end point for monitoring treatment response.Online Repository Characteristic Pain intensity, median (IQR) Bivariable model Multivariable model∗ Crude β (95% CI) P value Adjusted β (95% CI) P value Sex Male 5.46 (3.35) 1.00 (reference) — 1.00 (reference) — Female 5.55 (3.48) 0.24 (−0.56 to 1.03) .56 0.20 (−0.52 to 0.91) .58 Race and ethnicity Black 6.25 (2.21) 1.38 (0.50 to 2.25) .002 1.28 (0.53 to 2.03) .001 Other/multiracial 5.80 (3.43) 0.55 (−0.38 to 1.49) .24 0.67 (−0.23 to 1.56) .14 White 5.04 (3.32) 1.00 (reference) — 1.00 (reference) — Current age (y) 1-4 6.06 (3.34) −0.24 (−1.37 to 0.89) .68 −0.23 (−1.26 to 0.81) .67 5-7 3.72 (2.22) −1.38 (−2.41 to −0.34) .01 −1.25 (−2.18 to −0.32) .009 8-12 6.14 (2.03) 0.41 (−0.66 to 1.47) .45 0.16 (−0.89 to 1.22) .76 13-17 5.50 (3.50) 1.00 (reference) — 1.00 (reference) — Proxy POEM AD severity Almost clear/mild 3.13 (1.86) 1.00 (reference) — 1.00 (reference) — Moderate-very severe 5.73 (3.17) 2.18 (1.26 to 3.09) |
doi_str_mv | 10.1016/j.jaip.2021.12.012 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9275595</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2213219821014070</els_id><sourcerecordid>2647163609</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-42345f4f2c60afef634aa9c50bff69211d1303374458afddfec32e530d6361143</originalsourceid><addsrcrecordid>eNp9kcFKHTEUhkNpUbG-gIsy4KabO81JMjN3oAhWbCsobtp1iMmJN9OZZJpkLL69uVwV20WzSAL5zs85-Qg5BloDhfbTUA_KzTWjDGpgNQX2hhwwBnzFGIW3z3fo1_vkKKWBlrWGjgq6R_a56BshgB2Q6y9LNOgr5U2lNyoqnTG6lJ1OVbBV-uV8NauyqSn4u4K40cTC_3F5U6kcZqcrg3FS2WWX3pN3Vo0Jj57OQ_Lz68WP8--rq5tvl-dnVyst1jyvBOOiscIy3VJl0bZcKNXrht5a2_YMwACnnHdCNGtljbGoOcOGU9PyFkDwQ3K6y52X2wmNRp-jGuUc3aTigwzKyb9fvNvIu3Ave9Y1Td-UgI9PATH8XjBlObmkcRyVx7AkyVoQXQu8h4Ke_IMOYYm-jFco0UFpifaFYjtKx5BSRPvSDFC5FSYHuRUmt8IkMFmElaIPr8d4KXnWU4DPOwDLZ947jDJph16jcRF1lia4_-U_AgK0ptk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2647163609</pqid></control><display><type>article</type><title>Burden and characteristics of skin pain among children with atopic dermatitis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Cheng, Brian T. ; Paller, Amy S. ; Griffith, James W. ; Silverberg, Jonathan I. ; Fishbein, Anna B.</creator><creatorcontrib>Cheng, Brian T. ; Paller, Amy S. ; Griffith, James W. ; Silverberg, Jonathan I. ; Fishbein, Anna B.</creatorcontrib><description>Clinical Implications Skin pain is a distinct, burdensome symptom of childhood atopic dermatitis, with heterogeneous presentation and multiple atopic dermatitis phenotypes. [...]skin pain intensity is associated with significant decrements in quality of life, independent of atopic dermatitis severity. Median skin pain intensity was 5.5 and was more intense in children with more severe disease. [...]skin pain intensity was associated with worse overall QOL in disease severity–adjusted models, similar to previous studies that found that AD-induced pruritus is associated with worse QOL.3 Yet, it is unclear whether the differences in QOL are clinically significant. Skin pain is a distinct, burdensome symptom of childhood AD with heterogeneous presentation and AD phenotypes. [...]skin pain intensity was associated with significant decrements on QOL, independent of disease severity. Given the link between skin pain and the severity of AD, skin pain may be an important end point for monitoring treatment response.Online Repository Characteristic Pain intensity, median (IQR) Bivariable model Multivariable model∗ Crude β (95% CI) P value Adjusted β (95% CI) P value Sex Male 5.46 (3.35) 1.00 (reference) — 1.00 (reference) — Female 5.55 (3.48) 0.24 (−0.56 to 1.03) .56 0.20 (−0.52 to 0.91) .58 Race and ethnicity Black 6.25 (2.21) 1.38 (0.50 to 2.25) .002 1.28 (0.53 to 2.03) .001 Other/multiracial 5.80 (3.43) 0.55 (−0.38 to 1.49) .24 0.67 (−0.23 to 1.56) .14 White 5.04 (3.32) 1.00 (reference) — 1.00 (reference) — Current age (y) 1-4 6.06 (3.34) −0.24 (−1.37 to 0.89) .68 −0.23 (−1.26 to 0.81) .67 5-7 3.72 (2.22) −1.38 (−2.41 to −0.34) .01 −1.25 (−2.18 to −0.32) .009 8-12 6.14 (2.03) 0.41 (−0.66 to 1.47) .45 0.16 (−0.89 to 1.22) .76 13-17 5.50 (3.50) 1.00 (reference) — 1.00 (reference) — Proxy POEM AD severity Almost clear/mild 3.13 (1.86) 1.00 (reference) — 1.00 (reference) — Moderate-very severe 5.73 (3.17) 2.18 (1.26 to 3.09) <.0001 1.89 (1.00 to 2.78) <.0001 Treatment type Systemic therapy No 6.00 (2.68) 1.00 (reference) — 1.00 (reference) — Yes 5.48 (3.52) 0.89 (−0.26 to 2.04) .13 0.94 (−0.18 to 2.07) .10 Topical therapy No 5.61 (3.51) 1.00 (reference) — 1.00 (reference) — Yes 4.20 (2.42) 0.87 (−0.11 to 1.85) .08 0.50 (−0.53 to 1.52) .34 POEM weekly characteristics Skin itchy 0-4 d 3.88 (3.14) 1.00 (reference) — 1.00 (reference) — 5-7 d 6.19 (2.26) 1.85 (1.12 to 2.58) <.0001 1.47 (0.68 to 2.27) .0004 Bleeding 0-4 d 5.15 (3.43) 1.00 (reference) — 1.00 (reference) — 5-7 d 6.75</description><identifier>ISSN: 2213-2198</identifier><identifier>EISSN: 2213-2201</identifier><identifier>DOI: 10.1016/j.jaip.2021.12.012</identifier><identifier>PMID: 34954412</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Age ; Atopic dermatitis ; Child ; Children ; Children & youth ; Dermatitis ; Dermatitis, Atopic - epidemiology ; Eczema ; Females ; Humans ; Pain ; Parents & parenting ; Phenotypes ; Pruritus ; Quality of life ; Race ; Regression analysis ; Skin Diseases ; Sleep ; Sociodemographics</subject><ispartof>The journal of allergy and clinical immunology in practice (Cambridge, MA), 2022-04, Vol.10 (4), p.1104-1106.e1</ispartof><rights>2021 American Academy of Allergy, Asthma & Immunology</rights><rights>2021. American Academy of Allergy, Asthma & Immunology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-42345f4f2c60afef634aa9c50bff69211d1303374458afddfec32e530d6361143</citedby><cites>FETCH-LOGICAL-c483t-42345f4f2c60afef634aa9c50bff69211d1303374458afddfec32e530d6361143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34954412$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cheng, Brian T.</creatorcontrib><creatorcontrib>Paller, Amy S.</creatorcontrib><creatorcontrib>Griffith, James W.</creatorcontrib><creatorcontrib>Silverberg, Jonathan I.</creatorcontrib><creatorcontrib>Fishbein, Anna B.</creatorcontrib><title>Burden and characteristics of skin pain among children with atopic dermatitis</title><title>The journal of allergy and clinical immunology in practice (Cambridge, MA)</title><addtitle>J Allergy Clin Immunol Pract</addtitle><description>Clinical Implications Skin pain is a distinct, burdensome symptom of childhood atopic dermatitis, with heterogeneous presentation and multiple atopic dermatitis phenotypes. [...]skin pain intensity is associated with significant decrements in quality of life, independent of atopic dermatitis severity. Median skin pain intensity was 5.5 and was more intense in children with more severe disease. [...]skin pain intensity was associated with worse overall QOL in disease severity–adjusted models, similar to previous studies that found that AD-induced pruritus is associated with worse QOL.3 Yet, it is unclear whether the differences in QOL are clinically significant. Skin pain is a distinct, burdensome symptom of childhood AD with heterogeneous presentation and AD phenotypes. [...]skin pain intensity was associated with significant decrements on QOL, independent of disease severity. Given the link between skin pain and the severity of AD, skin pain may be an important end point for monitoring treatment response.Online Repository Characteristic Pain intensity, median (IQR) Bivariable model Multivariable model∗ Crude β (95% CI) P value Adjusted β (95% CI) P value Sex Male 5.46 (3.35) 1.00 (reference) — 1.00 (reference) — Female 5.55 (3.48) 0.24 (−0.56 to 1.03) .56 0.20 (−0.52 to 0.91) .58 Race and ethnicity Black 6.25 (2.21) 1.38 (0.50 to 2.25) .002 1.28 (0.53 to 2.03) .001 Other/multiracial 5.80 (3.43) 0.55 (−0.38 to 1.49) .24 0.67 (−0.23 to 1.56) .14 White 5.04 (3.32) 1.00 (reference) — 1.00 (reference) — Current age (y) 1-4 6.06 (3.34) −0.24 (−1.37 to 0.89) .68 −0.23 (−1.26 to 0.81) .67 5-7 3.72 (2.22) −1.38 (−2.41 to −0.34) .01 −1.25 (−2.18 to −0.32) .009 8-12 6.14 (2.03) 0.41 (−0.66 to 1.47) .45 0.16 (−0.89 to 1.22) .76 13-17 5.50 (3.50) 1.00 (reference) — 1.00 (reference) — Proxy POEM AD severity Almost clear/mild 3.13 (1.86) 1.00 (reference) — 1.00 (reference) — Moderate-very severe 5.73 (3.17) 2.18 (1.26 to 3.09) <.0001 1.89 (1.00 to 2.78) <.0001 Treatment type Systemic therapy No 6.00 (2.68) 1.00 (reference) — 1.00 (reference) — Yes 5.48 (3.52) 0.89 (−0.26 to 2.04) .13 0.94 (−0.18 to 2.07) .10 Topical therapy No 5.61 (3.51) 1.00 (reference) — 1.00 (reference) — Yes 4.20 (2.42) 0.87 (−0.11 to 1.85) .08 0.50 (−0.53 to 1.52) .34 POEM weekly characteristics Skin itchy 0-4 d 3.88 (3.14) 1.00 (reference) — 1.00 (reference) — 5-7 d 6.19 (2.26) 1.85 (1.12 to 2.58) <.0001 1.47 (0.68 to 2.27) .0004 Bleeding 0-4 d 5.15 (3.43) 1.00 (reference) — 1.00 (reference) — 5-7 d 6.75</description><subject>Age</subject><subject>Atopic dermatitis</subject><subject>Child</subject><subject>Children</subject><subject>Children & youth</subject><subject>Dermatitis</subject><subject>Dermatitis, Atopic - epidemiology</subject><subject>Eczema</subject><subject>Females</subject><subject>Humans</subject><subject>Pain</subject><subject>Parents & parenting</subject><subject>Phenotypes</subject><subject>Pruritus</subject><subject>Quality of life</subject><subject>Race</subject><subject>Regression analysis</subject><subject>Skin Diseases</subject><subject>Sleep</subject><subject>Sociodemographics</subject><issn>2213-2198</issn><issn>2213-2201</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFKHTEUhkNpUbG-gIsy4KabO81JMjN3oAhWbCsobtp1iMmJN9OZZJpkLL69uVwV20WzSAL5zs85-Qg5BloDhfbTUA_KzTWjDGpgNQX2hhwwBnzFGIW3z3fo1_vkKKWBlrWGjgq6R_a56BshgB2Q6y9LNOgr5U2lNyoqnTG6lJ1OVbBV-uV8NauyqSn4u4K40cTC_3F5U6kcZqcrg3FS2WWX3pN3Vo0Jj57OQ_Lz68WP8--rq5tvl-dnVyst1jyvBOOiscIy3VJl0bZcKNXrht5a2_YMwACnnHdCNGtljbGoOcOGU9PyFkDwQ3K6y52X2wmNRp-jGuUc3aTigwzKyb9fvNvIu3Ave9Y1Td-UgI9PATH8XjBlObmkcRyVx7AkyVoQXQu8h4Ke_IMOYYm-jFco0UFpifaFYjtKx5BSRPvSDFC5FSYHuRUmt8IkMFmElaIPr8d4KXnWU4DPOwDLZ947jDJph16jcRF1lia4_-U_AgK0ptk</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Cheng, Brian T.</creator><creator>Paller, Amy S.</creator><creator>Griffith, James W.</creator><creator>Silverberg, Jonathan I.</creator><creator>Fishbein, Anna B.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220401</creationdate><title>Burden and characteristics of skin pain among children with atopic dermatitis</title><author>Cheng, Brian T. ; Paller, Amy S. ; Griffith, James W. ; Silverberg, Jonathan I. ; Fishbein, Anna B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-42345f4f2c60afef634aa9c50bff69211d1303374458afddfec32e530d6361143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age</topic><topic>Atopic dermatitis</topic><topic>Child</topic><topic>Children</topic><topic>Children & youth</topic><topic>Dermatitis</topic><topic>Dermatitis, Atopic - epidemiology</topic><topic>Eczema</topic><topic>Females</topic><topic>Humans</topic><topic>Pain</topic><topic>Parents & parenting</topic><topic>Phenotypes</topic><topic>Pruritus</topic><topic>Quality of life</topic><topic>Race</topic><topic>Regression analysis</topic><topic>Skin Diseases</topic><topic>Sleep</topic><topic>Sociodemographics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cheng, Brian T.</creatorcontrib><creatorcontrib>Paller, Amy S.</creatorcontrib><creatorcontrib>Griffith, James W.</creatorcontrib><creatorcontrib>Silverberg, Jonathan I.</creatorcontrib><creatorcontrib>Fishbein, Anna B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The journal of allergy and clinical immunology in practice (Cambridge, MA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cheng, Brian T.</au><au>Paller, Amy S.</au><au>Griffith, James W.</au><au>Silverberg, Jonathan I.</au><au>Fishbein, Anna B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Burden and characteristics of skin pain among children with atopic dermatitis</atitle><jtitle>The journal of allergy and clinical immunology in practice (Cambridge, MA)</jtitle><addtitle>J Allergy Clin Immunol Pract</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>10</volume><issue>4</issue><spage>1104</spage><epage>1106.e1</epage><pages>1104-1106.e1</pages><issn>2213-2198</issn><eissn>2213-2201</eissn><abstract>Clinical Implications Skin pain is a distinct, burdensome symptom of childhood atopic dermatitis, with heterogeneous presentation and multiple atopic dermatitis phenotypes. [...]skin pain intensity is associated with significant decrements in quality of life, independent of atopic dermatitis severity. Median skin pain intensity was 5.5 and was more intense in children with more severe disease. [...]skin pain intensity was associated with worse overall QOL in disease severity–adjusted models, similar to previous studies that found that AD-induced pruritus is associated with worse QOL.3 Yet, it is unclear whether the differences in QOL are clinically significant. Skin pain is a distinct, burdensome symptom of childhood AD with heterogeneous presentation and AD phenotypes. [...]skin pain intensity was associated with significant decrements on QOL, independent of disease severity. Given the link between skin pain and the severity of AD, skin pain may be an important end point for monitoring treatment response.Online Repository Characteristic Pain intensity, median (IQR) Bivariable model Multivariable model∗ Crude β (95% CI) P value Adjusted β (95% CI) P value Sex Male 5.46 (3.35) 1.00 (reference) — 1.00 (reference) — Female 5.55 (3.48) 0.24 (−0.56 to 1.03) .56 0.20 (−0.52 to 0.91) .58 Race and ethnicity Black 6.25 (2.21) 1.38 (0.50 to 2.25) .002 1.28 (0.53 to 2.03) .001 Other/multiracial 5.80 (3.43) 0.55 (−0.38 to 1.49) .24 0.67 (−0.23 to 1.56) .14 White 5.04 (3.32) 1.00 (reference) — 1.00 (reference) — Current age (y) 1-4 6.06 (3.34) −0.24 (−1.37 to 0.89) .68 −0.23 (−1.26 to 0.81) .67 5-7 3.72 (2.22) −1.38 (−2.41 to −0.34) .01 −1.25 (−2.18 to −0.32) .009 8-12 6.14 (2.03) 0.41 (−0.66 to 1.47) .45 0.16 (−0.89 to 1.22) .76 13-17 5.50 (3.50) 1.00 (reference) — 1.00 (reference) — Proxy POEM AD severity Almost clear/mild 3.13 (1.86) 1.00 (reference) — 1.00 (reference) — Moderate-very severe 5.73 (3.17) 2.18 (1.26 to 3.09) <.0001 1.89 (1.00 to 2.78) <.0001 Treatment type Systemic therapy No 6.00 (2.68) 1.00 (reference) — 1.00 (reference) — Yes 5.48 (3.52) 0.89 (−0.26 to 2.04) .13 0.94 (−0.18 to 2.07) .10 Topical therapy No 5.61 (3.51) 1.00 (reference) — 1.00 (reference) — Yes 4.20 (2.42) 0.87 (−0.11 to 1.85) .08 0.50 (−0.53 to 1.52) .34 POEM weekly characteristics Skin itchy 0-4 d 3.88 (3.14) 1.00 (reference) — 1.00 (reference) — 5-7 d 6.19 (2.26) 1.85 (1.12 to 2.58) <.0001 1.47 (0.68 to 2.27) .0004 Bleeding 0-4 d 5.15 (3.43) 1.00 (reference) — 1.00 (reference) — 5-7 d 6.75</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34954412</pmid><doi>10.1016/j.jaip.2021.12.012</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2213-2198 |
ispartof | The journal of allergy and clinical immunology in practice (Cambridge, MA), 2022-04, Vol.10 (4), p.1104-1106.e1 |
issn | 2213-2198 2213-2201 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9275595 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Age Atopic dermatitis Child Children Children & youth Dermatitis Dermatitis, Atopic - epidemiology Eczema Females Humans Pain Parents & parenting Phenotypes Pruritus Quality of life Race Regression analysis Skin Diseases Sleep Sociodemographics |
title | Burden and characteristics of skin pain among children with atopic dermatitis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T01%3A49%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Burden%20and%20characteristics%20of%20skin%20pain%20among%20children%20with%20atopic%20dermatitis&rft.jtitle=The%20journal%20of%20allergy%20and%20clinical%20immunology%20in%20practice%20(Cambridge,%20MA)&rft.au=Cheng,%20Brian%20T.&rft.date=2022-04-01&rft.volume=10&rft.issue=4&rft.spage=1104&rft.epage=1106.e1&rft.pages=1104-1106.e1&rft.issn=2213-2198&rft.eissn=2213-2201&rft_id=info:doi/10.1016/j.jaip.2021.12.012&rft_dat=%3Cproquest_pubme%3E2647163609%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2647163609&rft_id=info:pmid/34954412&rft_els_id=S2213219821014070&rfr_iscdi=true |